Placebo
INOVA-2023-169
Phase 2 small_molecule active
Quick answer
Placebo for Acute Respiratory Distress Syndrome is a Phase 2 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- Acute Respiratory Distress Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active